Comparison of analytical performance of two single-step measurement devices of B-type natriuretic peptide

International Heart Journal

Volumn 53, Issue 5, 2012, Pages 320-323

  Ishida, Junichi ^a   Suzuki, Toru ^a,b   Aizawa, Kenichi ^a   Sawaki, Daigo ^a,b   Nagai, Ryozo ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Congestive heart failure; Point of care

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIMIT OF DETECTION; MEDICAL DEVICE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CHROMATOGRAPHY; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS;

EID: 84867909936     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.53.320     Document Type: Article

References (13)

1. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90.
2. Maisel AS, Nakao K, Ponikowski P, et al. Japanese-Western consensus meeting on biomarkers. Int Heart J 2011; 52: 253-65.
3. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
4. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7.
5. Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983; 21: 709-20.
6. Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay. Clin Lab 2001; 47: 29-33.
7. Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001; 47: 591-4.
8. Segawa T, Nakamura M, Itai K, Onoda T, Okayama A, Hiramori K. Plasma B-type natriuretic peptide levels and risk factors for congestive heart failure in a Japanese general population. Int Heart J 2005; 46: 465-75.
9. Kanda H, Kita Y, Okamura T, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 2005; 19: 165-72.
10. Sugisawa T, Kishimoto I, Kokubo Y, Makino H, Miyamoto Y, Yoshimasa Y. Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study. Endocr J 2010; 57: 727-33.
11. Koizumi M, Watanabe H, Kaneko Y, et al. Impact of obesity on plasma B-type natriuretic peptide levels in Japanese communitybased subjects. Heart Vessels 2012; 27: 287-94.
12. Nomura H, Hayashi T, Esaki T, et al. Standardization of plasma brain natriuretic peptide concentrations in older Japanese-relationship to latent renal dysfunction and ischemic heart disease. J Am Geriatr Soc 2002; 50: 1504-9.
13. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-9.